top of page
Search
GLP-1s Are a Miracle Drug… But What if Your Members Can’t Afford the Miracle?
In the world of chronic disease and weight management, few breakthroughs have generated as much excitement—or delivered as much...
Eric Levin, CEO
Apr 9
The Copay Maximizer Program Dilemma: What Plan Sponsors Need to Know
When it comes to managing pharmacy benefits, plan sponsors face a difficult balancing act—supporting members' access to necessary...
Scripta
Mar 17
The Impact of FDA Layoffs on Drug Safety & Shortages
The recent workforce reductions at the FDA could significantly impact its ability to effectively manage the safety, efficacy and...
Scripta
Mar 11
The Ultimate Guide to Shopping for GLP-1s for Weight Loss: A Plan Sponsor's Perspective
As GLP-1 medications for weight loss continue exploding in popularity, plan sponsors will need to make important decisions about how to...
Ferrin Williams, PharmD MBA
Feb 10
FTC's Interim Staff Report on PBMs: Why Transparency Tools are the Prescription for Change
The Federal Trade Commission's (FTC) second interim staff report  shines a light on critical issues surrounding prescription drug costs...
Ferrin Williams, PharmD MBA
Jan 21
Where Does Scripta Fit into Pharmacy Solutions?
For decades, healthcare has often left consumers with little control over one of the most personal aspects of their lives: buying...
Ferrin Williams, PharmD MBA
Nov 14, 2024
Blog
bottom of page